Travere Therapeutics
TVTX
TVTX
126 hedge funds and large institutions have $1.09B invested in Travere Therapeutics in 2015 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+45
Holders Change %
+55.56%
% of All Funds
3.4%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.22%
New
53
Increased
40
Reduced
26
Closed
8
Calls
$45.5M
Puts
$6.75M
Net Calls
+$38.8M
Net Calls Change
-$2.88M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$30.8M |
| 2 |
Bank of New York Mellon
New York
|
+$11M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$10.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.5M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$9.7M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$26.5M |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$20.6M |
| 3 |
Goldman Sachs
New York
|
-$15.6M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$10.8M |
| 5 |
Jennison Associates
New York
|
-$9.16M |
